Plain-English translation of NCT07250997 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a new laser device called PALLAS that uses ultraviolet light to treat skin conditions like vitiligo, psoriasis, alopecia areata, and atopic dermatitis. The PALLAS laser is designed to be more stable and reliable than older laser systems used for these conditions, with the goal of making treatments more effective and reducing unwanted side effects like skin burns.
Current ultraviolet laser treatments for skin conditions can be unpredictable in their energy output and are expensive to maintain. This trial exists to see whether the new treatment performs better and more safely than existing options.
You likely qualify if…
You likely don't qualify if…
You would attend treatment sessions at the study center in Szeged, Hungary, where researchers would use the PALLAS laser on the affected areas of your skin (typically the face, hands, arms, feet, or legs). The study will enroll about 50 people total and will evaluate how well the treatment works for your specific skin condition.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Hungary
Sponsor
Szeged University
Enrollment target
~50 participants
Started
December 2025
Primary completion
December 2026
Age range
18 Years – 65 Years
Last updated on clinicaltrials.gov in February 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Lajos Kemény, professor, MD, DSc, MHAS
Szeged University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.